Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 · New England Journal of Medicine · 5,710 citations
https://doi.org/10.1056/nejmoa065044
C
Cezary Szczylik
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
470
Papers
38.4K
Citations
65
h-index
203
i10-index
Cezary Szczylik is an academic researcher. The author has contributed to research in topics: Renal cell carcinoma treatment & Renal and related cancers & Cancer Genomics and Diagnostics. The author has an h-index of 65, co-authored 400 publications.
ORCID: 0000-0002-2524-2810Papers by this author
worksSorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 · New England Journal of Medicine · 4,750 citations
https://doi.org/10.1056/nejmoa060655
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
2023 · New England Journal of Medicine · 142 citations
https://doi.org/10.1056/nejmoa2212851
The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis
2015 · Stem Cell Reviews and Reports · 118 citations
https://doi.org/10.1007/s12015-015-9611-y
Chromophobe renal cell cancer - review of the literature and potential methods of treating metastatic disease
2009 · Journal of Experimental & Clinical Cancer Research · 67 citations
https://doi.org/10.1186/1756-9966-28-134
Risk factors for brain relapse in HER2-positive metastatic breast cancer patients
2009 · Breast Cancer Research and Treatment · 55 citations
https://doi.org/10.1007/s10549-008-0275-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat